Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × Thalidomide × Clear all

NCT00003850 2013-02-08

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms